COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO, ANNONCE LE CLOSING FINAL DE SON NOUVEAU FONDS BIOFUND IV A 215 MILLIONS D’EUROS
Kurma Partners, membre du groupe Eurazeo, annonce la clôture finale de son nouveau fonds Biofund IV à 215 millions d'euros, renforçant son implication dans les biotechs disruptives en Europe -
COMMUNIQUÉ DE PRESSE
Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Hillcrest Energy Technologies announces finalization of A-Sample design for its 250 kW ZVS PCS1000 Grid Power Conversion System, targeting high power density & lower cost. Prototype demonstrations set for June 2026 -
-
COMMUNIQUÉ DE PRESSE
FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
Ferrosa Therapeutics announces USD 3.5 Million seed financing to advance first-in-class bispecific antibody program for anemia of inflammation. Company targets chronic kidney disease, autoimmune disease, and cancer -
COMMUNIQUÉ DE PRESSE
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
CorTec GmbH's Brain Interchange™ accepted into FDA Total Product Life Cycle Advisory Program (TAP), showcasing innovation in stroke motor rehabilitation. Third patient successfully implanted in NIH-funded trial -
-
COMMUNIQUÉ DE PRESSE
Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Lobe Sciences welcomes White House Executive Order supporting advancements in neurology and mental health treatments, focusing on scientific research and compound evaluation -
